Compounds useful as reversible inhibitors of cysteine proteases
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds
Boehringer Ingelheim Pharmaceuticals Inc.
A C A A C C C C C C C A C C C A A C A C A C C C A A C C A
A61P C07D A61P A61P C07D C04B C07D C07D C07D C07D C07D A61P C07D C07D C07D A61P A61P C07D A61P C07D A61P C07D C07D C07D A61P A61P C07D C07D A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yancey David Eugene R. Sanxing Weimin Leah L. Tina Marie Denice Mary David S. Michel Jose Erick Richard Roush
Ward Hickey Sun Liu Frye Morwick Spero Thomson Emmanuel Young